GGrantIndex
Sort

78,016 grants matching breast cancer

Risk Prediction for ER Negative Breast Cancer Recurrence

$603,134
Melissa L Bondy · Baylor College Of Medicine · R01 · FY2014 · CA

Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis

$603,125
James J. Manfredi · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

Immune cell control of ovarian cancer

$603,049
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit

$603,042
Anant Madabhushi · Emory University · U01 · FY2022 · CA

Development of novel selective Rac inhibitors for refractory leukemias

$603,034
David A Williams · Boston Children'S Hospital · R01 · FY2017 · CA

Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms

$603,025
Peggy Reynolds · University Of California, San Francisco · R01 · FY2018 · CA

Regulation of the Fanconi Anemia Pathway by Ubiquitination

$603,012
Alan David D'andrea · Dana-Farber Cancer Inst · R01 · FY2011 · DK

PESO: Materials and Multivariable Models to Predict Tissue Tropism in Metastasis

$603,000
Shelly Peyton · University Of Massachusetts Amherst · · FY2012 · MPS

Clinical Protocol and Data Management (Core 012)

$602,946
Dan Toby Vogl · University Of Pennsylvania · P30 · FY2018 · CA

Point-of-care cellular and molecular pathology of breast tumors on a cell phone

$602,938
Ashutosh Chilkoti · Duke University · R01 · FY2022 · CA

BREAST CANCER SURVEILLANCE RESEARCH IN COLORADO

$602,905
Cooper Institute · U01 · FY2004 · CA

Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes

$602,884
Tracy Onega · Dartmouth College · R01 · FY2011 · CA

An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.

$602,872
Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

RENEW Research-out to Enhance Wellness Older Survivors

$602,827
Duke University · R01 · FY2004 · CA

NCI National Clinical Trials Network-Network Lead Academic Participating Site

$602,729
Lawrence E Flaherty · Wayne State University · U10 · FY2015 · CA

Role Of Lipids In Colon, Breast, And Other Cancers

$602,723
Thomas Eling · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Group Phone-based Weight Control among Rural Breast Cancer Survivors

$602,708
Christie Befort · University Of Kansas Medical Center · R01 · FY2011 · CA

Development of Natural Product Leads as Anticancer Therapeutics

$602,680
John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors

$602,559
Qian Lu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials

$602,540
Raymond F Muzic · Case Western Reserve University · R01 · FY2016 · CA

Chemical Probes for Metabolic Pathway Discovery in Human Disease

$602,495
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2008 · CA

Multi-probe fluorescence imaging for rapid intra-operative tumor margin assessment

$602,494
Scott C Davis · Dartmouth College · R01 · FY2018 · CA

Novel Comprehensive Proteome Analyses of Metastasis

$602,469
Wistar Institute · R33 · FY2004 · CA

(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival

$602,462
Bette J Caan · Kaiser Foundation Research Institute · R01 · FY2016 · CA

Epidemiologic factors and survival by molecular subtypes of ovarian cancer

$602,370
Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA